Analysts lift Cardinal Health targets before earnings
Alpha Vantage · scanx.trade · · AI-summarised by FinFlash
Ahead of its Q1FY27 report on November 5, Cardinal Health drew price target hikes from Morgan Stanley to $286 and UBS to $295. Analysts expect EPS of $2.94, up 15.3% year-over-year, on revenue of $66.51 billion, citing anticipated margin expansion. Shares rose 3.6% to $261.93. Consensus target of $273.47 implies roughly 7.5% upside, with 14 Buy ratings and no Sells.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.